NA
BLUE

NewEdge Advisors’s bluebird bio BLUE Stock Holding History

NewEdge Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150
Closed -$732 – 3997
2025
Q1 		$732 Hold
150
– – ﹤0.01% 3662
2024
Q4 		$1.25K Hold
150
– – ﹤0.01% 3530
2024
Q3 		$1.56K Buy
150
+50
+50% +$831 ﹤0.01% 3436
2024
Q2 		$1.97K Sell
100
-100
-50% -$2K ﹤0.01% 3336
2024
Q1 		$5.12K Buy
200
+145
+264% +$3.72K ﹤0.01% 3130
2023
Q4 		$1.52K Hold
55
– – ﹤0.01% 3395
2023
Q3 		$3.34K Hold
55
– – ﹤0.01% 2920
2023
Q2 		$3.62K Hold
55
– – ﹤0.01% 2920
2023
Q1 		$3.5K Hold
55
– – ﹤0.01% 2888
2022
Q4 		$8 Buy
+55
New +$7.75K ﹤0.01% 3732
2021
Q1 		– Sell
-405
Closed -$227K – 1036
2020
Q4 		$227K Buy
+405
New +$257K 0.01% 853

Other funds holding BLUE

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NewEdge Advisors's BLUE Position: Q2 2025 in Review

NewEdge Advisors sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 150 shares — an estimated $732 sold.

NewEdge Advisors first reported a position in BLUE in Q4 2020 and held it in 11 quarters. The position peaked at $227K in Q4 2020. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • NewEdge Advisors reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • NewEdge Advisors sold 150 bluebird bio shares in Q2 2025, an estimated $732.
  • NewEdge Advisors first reported a position in bluebird bio in Q4 2020 and held it in 11 quarters.
  • NewEdge Advisors's bluebird bio position peaked at $227K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on NewEdge Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.